DVA
DaVita HealthCare Partners Inc
177.00$
+0.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.8% | -2.4% | +3.8% | +2.4% | +1.0% | -2.2% | +4.8% | +1.2% | +5.8% | -5.6% | +4.1% | – | |
| – | +3.4% | -2.8% | +3.0% | +0.4% | +3.4% | +0.6% | +1.0% | +3.1% | +11.3% | -9.8% | +2.1% | – | |
| – | -4.4% | -1.6% | +5.3% | +6.4% | -3.8% | -8.0% | +13.6% | -2.7% | -5.9% | +4.9% | +8.3% | – | |
| – | +6.5% | -9.7% | +1.5% | +7.0% | +5.3% | -9.7% | +10.3% | +0.4% | +14.0% | -10.7% | +0.4% | – | |
| – | +10.6% | -17.8% | +6.0% | +7.2% | -12.6% | +8.1% | +6.5% | +0.3% | -18.8% | +25.2% | 0.0% | – | |
| – | -21.4% | +24.1% | +4.7% | +5.6% | +5.7% | -22.4% | +22.5% | -6.0% | +9.0% | -12.6% | +18.5% | – | |
| – | -1.9% | +3.4% | -1.7% | +37.7% | +3.1% | -2.6% | +8.2% | +3.1% | -21.6% | +23.0% | +0.9% | – | |
| – | -23.6% | +28.6% | -0.1% | +0.5% | +10.8% | -30.8% | +28.8% | -16.3% | +23.9% | -10.8% | +27.5% | – | |
| – | -15.0% | +12.5% | +8.9% | +8.4% | -17.0% | -16.1% | +73.2% | -26.8% | +11.9% | -13.7% | +38.7% | – | |
| – | -38.9% | +59.1% | -7.1% | -3.6% | +20.8% | -37.2% | +22.4% | -24.6% | +55.8% | -15.7% | +34.4% | – | |
| – | -12.7% | +13.4% | -2.0% | +7.8% | +4.5% | -17.7% | +15.4% | -7.7% | +12.7% | -8.7% | +14.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.